2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Mee Kyoung | - |
dc.contributor.author | Ko, Seung-Hyun | - |
dc.contributor.author | Kim, Bo-Yeon | - |
dc.contributor.author | Kang, Eun Seok | - |
dc.contributor.author | Noh, Junghyun | - |
dc.contributor.author | Kim, Soo-Kyung | - |
dc.contributor.author | Park, Seok-O | - |
dc.contributor.author | Hur, Kyu Yeon | - |
dc.contributor.author | Chon, Suk | - |
dc.contributor.author | Moon, Min Kyong | - |
dc.contributor.author | Kim, Nan-Hee | - |
dc.contributor.author | Kim, Sang Yong | - |
dc.contributor.author | Rhee, Sang Youl | - |
dc.contributor.author | Lee, Kang-Woo | - |
dc.contributor.author | Kim, Jae Hyeon | - |
dc.contributor.author | Rhee, Eun-Jung | - |
dc.contributor.author | Chun, SungWan | - |
dc.contributor.author | Yu, Sung Hoon | - |
dc.contributor.author | Kim, Dae Jung | - |
dc.contributor.author | Kwon, Hyuk-Sang | - |
dc.contributor.author | Park, Kyong Soo | - |
dc.date.accessioned | 2021-08-11T09:24:52Z | - |
dc.date.available | 2021-08-11T09:24:52Z | - |
dc.date.issued | 2019-08 | - |
dc.identifier.issn | 2233-6079 | - |
dc.identifier.issn | 2233-6087 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/4339 | - |
dc.description.abstract | The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한당뇨병학회 | - |
dc.title | 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.4093/dmj.2019.0137 | - |
dc.identifier.scopusid | 2-s2.0-85072118225 | - |
dc.identifier.wosid | 000482226400002 | - |
dc.identifier.bibliographicCitation | Diabetes and Metabolism Journal, v.43, no.4, pp 398 - 406 | - |
dc.citation.title | Diabetes and Metabolism Journal | - |
dc.citation.volume | 43 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 398 | - |
dc.citation.endPage | 406 | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002493308 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.subject.keywordPlus | ESTABLISHED CARDIOVASCULAR-DISEASE | - |
dc.subject.keywordPlus | BLOOD-PRESSURE CONTROL | - |
dc.subject.keywordPlus | BARIATRIC SURGERY | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | EMPAGLIFLOZIN | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | LIRAGLUTIDE | - |
dc.subject.keywordPlus | PROGRESSION | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordAuthor | Diabetes mellitus | - |
dc.subject.keywordAuthor | type 2 | - |
dc.subject.keywordAuthor | Diagnosis | - |
dc.subject.keywordAuthor | Practice guideline | - |
dc.subject.keywordAuthor | Therapeutics | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.